Previous Close | 6.54 |
Open | N/A |
Bid | 5.80 |
Ask | 7.30 |
Strike | 7.50 |
Expire Date | 2024-07-19 |
Day's Range | 6.54 - 6.54 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Discover how VolitionRX Ltd is enhancing its financial structure and advancing key technologies for future growth.
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced financial results and a business update for the first quarter of 2024. Volition management will host a conference call tomorrow, May 14 at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details can be found below.
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Tuesday, May 14 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the first quarter 2024, in addition to providing a business update. Details of this event can also be found below.